LOS ANGELES -- The HOPE trial made another case for extending the therapeutic window for IV thrombolysis in acute ischemic stroke, potentially widening the pool of people eligible for therapy. Among ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback